Home

Addus HomeCare Corporation - Common Stock (ADUS)

100.85
-0.92 (-0.90%)
NASDAQ · Last Trade: Apr 11th, 7:08 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 14.1%. This performance was worse than the S&P 500’s 9.3% decline.
Via StockStory · April 11, 2025
Senior Health, Home Health & Hospice Stocks Q4 Recap: Benchmarking The Pennant Group (NASDAQ:PNTG)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at The Pennant Group (NASDAQ:PNTG) and its peers.
Via StockStory · April 11, 2025
What Analysts Are Saying About Addus HomeCare Stockbenzinga.com
Via Benzinga · April 10, 2025
Q4 Rundown: Addus HomeCare (NASDAQ:ADUS) Vs Other Senior Health, Home Health & Hospice Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at senior health, home health & hospice stocks, starting with Addus HomeCare (NASDAQ:ADUS).
Via StockStory · April 7, 2025
Analyst Expectations For Addus HomeCare's Futurebenzinga.com
Via Benzinga · February 27, 2025
Deep Dive Into Addus HomeCare Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 24, 2025
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q4 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest Of The Pack
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers.
Via StockStory · March 28, 2025
3 Reasons ADUS is Risky and 1 Stock to Buy Instead
Addus HomeCare has gotten torched over the last six months - since September 2024, its stock price has dropped 26.9% to $95.71 per share. This may have investors wondering how to approach the situation.
Via StockStory · March 27, 2025
Senior Health, Home Health & Hospice Stocks Q4 Earnings: Option Care Health (NASDAQ:OPCH) Best of the Bunch
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
Via StockStory · March 21, 2025
Is NASDAQ:ADUS a Suitable Choice for Quality Investing?chartmill.com
Why Quality Investors May Find ADDUS HOMECARE CORP (NASDAQ:ADUS) Attractive.
Via Chartmill · January 16, 2025
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing?chartmill.com
Should Quality-Oriented Investors Explore ADDUS HOMECARE CORP (NASDAQ:ADUS)?
Via Chartmill · December 19, 2024
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Pack
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group (NYSE:MD) and its peers.
Via StockStory · March 19, 2025
BrightSpring Health Services (BTSG) Q4 Earnings: What To Expect
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Via StockStory · March 5, 2025
What To Expect From Chemed’s (CHE) Q4 Earnings
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what to expect.
Via StockStory · February 25, 2025
Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect
Alternate site health provider Option Care Health (NASDAQ:OPCH) will be reporting earnings tomorrow before market open. Here’s what to look for.
Via StockStory · February 25, 2025
Addus HomeCare (NASDAQ:ADUS) Surprises With Q4 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of $1.38 per share was 1.6% above analysts’ consensus estimates.
Via StockStory · February 24, 2025
Earnings Scheduled For February 24, 2025benzinga.com
Via Benzinga · February 24, 2025
Addus HomeCare (ADUS) To Report Earnings Tomorrow: Here Is What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings tomorrow after market hours. Here’s what to look for.
Via StockStory · February 23, 2025
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers.
Via StockStory · February 14, 2025
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers.
Via StockStory · February 14, 2025
Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).
Via StockStory · February 11, 2025
Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.
Via StockStory · February 11, 2025
DaVita Stock Sees Improved Relative Strength Ratinginvestors.com
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
Via Investor's Business Daily · December 20, 2024
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analystbenzinga.com
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth.
Via Benzinga · December 16, 2024
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · December 16, 2024